N-(2-aminoethyl)-N-(cyclohexylmethyl)pyridine-2-sulfonamide | 1247018-73-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: N-(2-aminoethyl)-N-(cyclohexylmethyl)pyridine-2-sulfonamide
• CAS: 1247018-73-0
• 化学式: C₁₄H₂₃N₃O₂S
• 分子量: 297.422
• InChiKey: IZOOCLHZZJTLQT-UHFFFAOYSA-N

物化性质

• 沸点：
  465.1±51.0 °C(Predicted)
• 密度：
  1.185±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  20
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  84.7
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  对氟苯腈 、 N-(2-aminoethyl)-N-(cyclohexylmethyl)pyridine-2-sulfonamide 在 N,N-二异丙基乙胺 作用下， 以 二甲基亚砜 为溶剂， 反应 48.0h， 以89%的产率得到N-(2-(4-cyanophenylamino)ethyl)-N-(cyclohexylmethyl)-pyridine-2-sulfonamide
  参考文献：
  名称：

  Structure-Based Design and Synthesis of Potent, Ethylenediamine-Based, Mammalian Farnesyltransferase Inhibitors as Anticancer Agents

  摘要：

  A potent class of anticancer. human farnesyltransferase (111:Tase) inhibitors has been identified by "piggy-backing" on potent, antimalarial inhibitors of Plosmodium falciparum farnesyltransferase (P/FTase). On the basis of a 4-Fold substituted ethylenediamine scaffold, the inhibitors are structurally simple and readily derivatized, facilitating the extensive structure activity relationship (SA R) study reported herein. Our most potent inhibitor is compound If, which exhibited an in vitro hFTase IC50 value of 25 nm and a whole cell H-Ras processing IC50 value of 90 nM. Moreover, it is noteworthy that several of our inhibitors proved highly selective For hFTase (up to 333-fold) over the related prenyltransferase enzyme geranylgeranyltransferase-I (GGTase-l). A crystal structure of inhibitor la co-crystallized with farnesyl pyrophosphate (FPP) in the active site of rat FTase illustrates that the para-benzonitrile moiety of la is stabilized by pi-pi stacking interaction with the Y361 beta residue, suggesting a structural explanation for the observed importance of this component of our inhibitors.

  DOI：

  10.1021/jm1001748
• 作为产物：
  描述：

  tert-butyl 2-(N-(cyclohexylmethyl)pyridine-2-sulfonamido)ethylcarbamate 在 盐酸 、 水 作用下， 以 异丙醇 为溶剂， 反应 1.0h， 以97%的产率得到N-(2-aminoethyl)-N-(cyclohexylmethyl)pyridine-2-sulfonamide
  参考文献：
  名称：

  Structure-Based Design and Synthesis of Potent, Ethylenediamine-Based, Mammalian Farnesyltransferase Inhibitors as Anticancer Agents

  摘要：

  A potent class of anticancer. human farnesyltransferase (111:Tase) inhibitors has been identified by "piggy-backing" on potent, antimalarial inhibitors of Plosmodium falciparum farnesyltransferase (P/FTase). On the basis of a 4-Fold substituted ethylenediamine scaffold, the inhibitors are structurally simple and readily derivatized, facilitating the extensive structure activity relationship (SA R) study reported herein. Our most potent inhibitor is compound If, which exhibited an in vitro hFTase IC50 value of 25 nm and a whole cell H-Ras processing IC50 value of 90 nM. Moreover, it is noteworthy that several of our inhibitors proved highly selective For hFTase (up to 333-fold) over the related prenyltransferase enzyme geranylgeranyltransferase-I (GGTase-l). A crystal structure of inhibitor la co-crystallized with farnesyl pyrophosphate (FPP) in the active site of rat FTase illustrates that the para-benzonitrile moiety of la is stabilized by pi-pi stacking interaction with the Y361 beta residue, suggesting a structural explanation for the observed importance of this component of our inhibitors.

  DOI：

  10.1021/jm1001748

文献信息

• Dual inhibitors of farnesyltransferase and geranylgeranyltransferase I
  申请人：H. Lee Moffitt Cancer Center and Research Institute, Inc.

  公开号：US09040563B2

  公开（公告）日：2015-05-26

  Many GTPases such as Ras, Ral and Rho require post-translational farnestylation or geranylgeranylation for mediating malignant transformation. Dual farnesyltransferase (FT) (FTI) and geranylgeranyltransferase-I (GGT-1) inhibitors (GGTI) were developed as anticancer agents from based on an ethylenediamine scaffold. On the basis of a 4-fold substituted ethylenediamine scaffold, the inhibitors are structurally simple and readily derivatized, facilitating extensive structure-activity relationship studies. The most potent inhibitor is compound exhibited an in vitro hFTase IC50 value of 25 nM and a whole cell H-Ras processing IC50 value of 90 nM. Several of the inhibitors proved highly selective for hFTase over the related prenyltransferase enzyme geranylgeranyltransferase-I (GGTase-I). A crystal structure of an inhibitor cocrystallized with farnesyl pyrophosphate in the active site of rat FTase illustrates that the para-benzonitrile moiety is stabilized by a π-π stacking interaction with the Y361β residue, suggesting an importance of this component of the inhibitors.

  许多GTP酶，如Ras、Ral和Rho，需要经过翻译后的法尼酰化或戊二烯基化才能介导恶性转化。基于乙二胺支架，开发了双法尼基转移酶（FT）（FTI）和戊二烯基转移酶-I（GGT-1）抑制剂（GGTI）作为抗癌药物。这些抑制剂的结构简单，易于衍生，便于进行广泛的结构活性关系研究。其中最有效的抑制剂在体外hFTase IC50值为25 nM，全细胞H-Ras处理IC50值为90 nM。其中几种抑制剂对相关的戊二烯基转移酶酶高度选择性。一种抑制剂与法尼酰焦磷酸在大鼠FTase的活性位点上共结晶的晶体结构表明，对苯二腈基团与Y361β残基的π-π堆叠相互作用稳定，这表明该抑制剂的这个组分很重要。
• DUAL INHIBITORS OF FARNESYLTRANSFERASE AND GERANYLGERANYLTRANSFERASE I
  申请人：H. Lee Moffitt Cancer Center and Research Institute, Inc.

  公开号：US20130190355A1

  公开（公告）日：2013-07-25

  Many GTPases such as Ras, Ral and Rho require post-translational farnestylation or geranylgeranylation for mediating malignant transformation. Dual farnesyltransferase (FT) (FTI) and geranylgeranyltransferase-I (GGT-1) inhibitors (GGTI) were developed as anticancer agents from based on an ethylenediamine scaffold. On the basis of a 4-fold substituted ethylenediamine scaffold, the inhibitors are structurally simple and readily derivatized, facilitating extensive structure-activity relationship studies. The most potent inhibitor is compound exhibited an in vitro hFTase IC 50 value of 25 nM and a whole cell H-Ras processing IC 50 value of 90 nM. Several of the inhibitors proved highly selective for hFTase over the related prenyltransferase enzyme geranylgeranyltransferase-I (GGTase-I). A crystal structure of an inhibitor cocrystallized with farnesyl pyrophosphate in the active site of rat FTase illustrates that the para-benzonitrile moiety is stabilized by a π-π stacking interaction with the Y361β residue, suggesting an importance of this component of the inhibitors.

  许多GTP酶如Ras、Ral和Rho需要经过翻酰基化或戊二烯基化的后翻译修饰，以介导恶性转化。双重翻酰基转移酶(FT)(FTI)和戊二烯基转移酶-I(GGT-1)抑制剂(GGTI)是基于乙二胺支架开发的抗癌剂。基于四倍取代乙二胺支架，这些抑制剂结构简单，易于衍生，便于进行广泛的构效关系研究。其中最有效的抑制剂表现出25 nM的体外hFTase IC50值和90 nM的整个细胞H-Ras处理IC50值。其中几种抑制剂对相关的戊二烯基转移酶酶(GGTase-I)高度选择性。一种抑制剂与磷酸戊二烯基共结晶于大鼠FTase的活性位点中的晶体结构表明，对苯二腈基团通过与Y361β残基的π-π堆积相互作用稳定，表明这些抑制剂的这个组分的重要性。
• US9040563B2
  申请人：——

  公开号：US9040563B2

  公开（公告）日：2015-05-26
• [EN] DUAL INHIBITORS OF FARNESYLTRANSFERASE AND GERANYLGERANYLTRANSFERASE I<br/>[FR] INHIBITEURS DOUBLES DE FARNÉSYLTRANSFÉRASE ET DE GÉRANYLGÉRANYLTRANSFÉRASE 1
  申请人：H LEE MOFFITT CANCER CT & RES

  公开号：WO2012034038A2

  公开（公告）日：2012-03-15

  Many GTPases such as Ras, Ral and Rho require post-translational farnestylation or geranylgeranylation for mediating malignant transformation. Dual farnesyltransferase (FT) (FTI) and geranylgeranyltransferase-l (GGT-1) inhibitors (GGTI) were developed as anticancer agents from based on an ethylenediamine scaffold. On the basis of a 4-fold substituted ethylenediamine scaffold, the inhibitors are structurally simple and readily derivatized, facilitating extensive structure-activity relationship studies. The most potent inhibitor is compound exhibited an in vitro hFTase IC50 value of 25 nM and a whole cell H-Ras processing IC50 value of 90 nM. Several of the inhibitors proved highly selective for hFTase over the related prenyltransferase enzyme geranylgeranyltransferase-l (GGTase-l). A crystal structure of an inhibitor cocrystallized with farnesyl pyrophosphate in the active site of rat FTase illustrates that the para-benzonitrile moiety is stabilized by a π-π stacking interaction with the Y361 β residue, suggesting an importance of this component of the inhibitors.
• Structure-Based Design and Synthesis of Potent, Ethylenediamine-Based, Mammalian Farnesyltransferase Inhibitors as Anticancer Agents
  作者：Steven Fletcher、Erin Pusateri Keaney、Christopher G. Cummings、Michelle A. Blaskovich、Michael A. Hast、Matthew P. Glenn、Sung-Youn Chang、Cynthia J. Bucher、Ryan J. Floyd、William P. Katt、Michael H. Gelb、Wesley C. Van Voorhis、Lorena S. Beese、Said M. Sebti、Andrew D. Hamilton

  DOI：10.1021/jm1001748

  日期：2010.10.14

  A potent class of anticancer. human farnesyltransferase (111:Tase) inhibitors has been identified by "piggy-backing" on potent, antimalarial inhibitors of Plosmodium falciparum farnesyltransferase (P/FTase). On the basis of a 4-Fold substituted ethylenediamine scaffold, the inhibitors are structurally simple and readily derivatized, facilitating the extensive structure activity relationship (SA R) study reported herein. Our most potent inhibitor is compound If, which exhibited an in vitro hFTase IC50 value of 25 nm and a whole cell H-Ras processing IC50 value of 90 nM. Moreover, it is noteworthy that several of our inhibitors proved highly selective For hFTase (up to 333-fold) over the related prenyltransferase enzyme geranylgeranyltransferase-I (GGTase-l). A crystal structure of inhibitor la co-crystallized with farnesyl pyrophosphate (FPP) in the active site of rat FTase illustrates that the para-benzonitrile moiety of la is stabilized by pi-pi stacking interaction with the Y361 beta residue, suggesting a structural explanation for the observed importance of this component of our inhibitors.